Overview
The present study aims to collect early bright field image of patient-derived organoids with ovarian cancer. By leveraging artificial intelligence, this study will seek to construct and refine algorithms that able to predict growth of ovarian cancer organoids.
Eligibility
Inclusion Criteria:
- Patients must have histologically confirmed diagnosis of epithelial ovarian cancer
- Patients received biopsy or puncture to obtain tumor tissues or malignant effusion
- Patients voluntarily participated in the study and signed informed consent.
Exclusion Criteria:
- Non-epithelial ovarian cancer
- No sufficient amount of tumor tissues or malignant effusion for organoids establishment.